Search

Your search keyword '"Garg AD"' showing total 146 results

Search Constraints

Start Over You searched for: Author "Garg AD" Remove constraint Author: "Garg AD"
146 results on '"Garg AD"'

Search Results

1. Multiomics and spatial mapping characterizes human CD8 + T cell states in cancer

2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

3. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

4. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

5. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy

7. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

9. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

10. Immunogenic cell death and DAMPs in cancer therapy.

11. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity

12. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

13. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

14. Trial watch: anticancer vaccination with dendritic cells.

17. An Immunometabolic Route for Activating cGAS/STING to Drive Anticancer Immunity.

18. Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab.

20. Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance.

21. Targeting conserved TIM3 + VISTA + tumor-associated macrophages overcomes resistance to cancer immunotherapy.

22. IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer.

23. A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma.

24. Circadian tumor infiltration and function of CD8 + T cells dictate immunotherapy efficacy.

25. Lymph node and tumor-associated PD-L1 + macrophages antagonize dendritic cell vaccines by suppressing CD8 + T cells.

26. The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapy.

27. A Metabolic Gene Survey Pinpoints Fucosylation as a Key Pathway Underlying the Suppressive Function of Regulatory T Cells in Cancer.

28. Single cell dynamics of tumor specificity vs bystander activity in CD8 + T cells define the diverse immune landscapes in colorectal cancer.

30. Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer.

32. Obesity-associated changes in molecular biology of primary breast cancer.

33. Trial watch: chemotherapy-induced immunogenic cell death in oncology.

34. Cellular and molecular features related to exceptional therapy response and extreme long-term survival in glioblastoma.

35. Apoptotic cell death in disease-Current understanding of the NCCD 2023.

36. Regulatory T-cell stability and functional plasticity in health and disease.

37. CD4 + helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment.

38. DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis.

39. The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology.

43. Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages.

44. Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates.

45. Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines.

46. Trial watch: Dendritic cell (DC)-based immunotherapy for cancer.

47. Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma.

48. A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncology.

49. Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1α kinase inhibitor KIRA6 through HSP60 targeting.

50. Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer.

Catalog

Books, media, physical & digital resources